Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epithelium.


Journal

Neoplasia (New York, N.Y.)
ISSN: 1476-5586
Titre abrégé: Neoplasia
Pays: United States
ID NLM: 100886622

Informations de publication

Date de publication:
12 2021
Historique:
received: 08 08 2021
revised: 06 10 2021
accepted: 08 11 2021
pubmed: 20 11 2021
medline: 5 3 2022
entrez: 19 11 2021
Statut: ppublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid tumors. Based on transcriptomic classifiers, basal-like and classical PDAC subtypes have been defined that differ in prognosis. Cells of both subtypes can coexist in individual tumors; however, the contribution of either clonal heterogeneity or microenvironmental cues to subtype heterogeneity is unclear. Here, we report the spatial tumor phenotype dynamics in a cohort of patients in whom PDAC infiltrated the duodenal wall, and identify the duodenal epithelium as a distinct PDAC microniche. We used serial multiplex quantitative immunohistochemistry (smq-IHC) for 24 proteins to phenotypically chart PDAC tumor cells in patients whose tumors infiltrated the duodenal epithelium. Additionally, we used a genetically engineered mouse model to study the PDAC cell phenotype in the small intestinal epithelium in a controlled genetic background. We show that pancreatic cancer cells revert to non-destructive growth upon integration into the duodenal epithelium, where they adopt traits of intestinal cell differentiation, associated with phenotypical stabilization of the classical subtype. The integrated tumor cells replace epithelial cells in an adenoma-like manner, as opposed to invasive growth in the submucosa. Finally, we show that this phenomenon is shared between species, by confirming duodenal integration and phenotypic switching in a genetic PDAC mouse model. Our results identify the duodenal epithelium as a distinct PDAC microniche and tightly link microenvironmental cue to cancer transcriptional subtypes. The phenomenon of "intestinal mimicry" provides a unique opportunity for the systematic investigation of microenvironmental influences on pancreatic cancer plasticity.

Identifiants

pubmed: 34798385
pii: S1476-5586(21)00097-X
doi: 10.1016/j.neo.2021.11.007
pmc: PMC8605302
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1300-1306

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that no conflicts of interest exist.

Auteurs

Benedek Bozóky (B)

Theme Cancer, Karolinska University Hospital, Solna 17176, Sweden; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Solnavägen 9, Solna 17165, Sweden.

Carlos Fernández Moro (C)

Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Huddinge 14186, Sweden; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Huddinge 14186, Sweden.

Carina Strell (C)

Department of Oncology-Pathology, Karolinska Institutet, Solna 17164, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala 75185, Sweden.

Natalie Geyer (N)

Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, Huddinge 14183, Sweden.

Rainer L Heuchel (RL)

Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Huddinge 14186, Sweden.

J Matthias Löhr (JM)

Theme Cancer, Karolinska University Hospital, Solna 17176, Sweden; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Huddinge 14186, Sweden.

Ingemar Ernberg (I)

Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Solnavägen 9, Solna 17165, Sweden.

Laszlo Szekely (L)

Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Huddinge 14186, Sweden; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Huddinge 14186, Sweden.

Marco Gerling (M)

Theme Cancer, Karolinska University Hospital, Solna 17176, Sweden; Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, Huddinge 14183, Sweden. Electronic address: marco.gerling@ki.se.

Béla Bozóky (B)

Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Huddinge 14186, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH